BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

UCB, Inc. 

1950 Lake Park Drive

Smyrna  Georgia  30080  U.S.A.
Phone: 770-437-5705 Fax: 770-437-5640


SEARCH JOBS






Collaborations

The Medicines Company  Contract manufacturing of Bivalirudin peptide active ingredient

Praecis Pharmaceuticals Incorporated  Contract manufacturing of Abarelix peptide active ingredient

Amgen  Contract manufacturing of Abarelix peptide active ingredient

Bausch & Lomb  Contract manufacturing of active pharmaceutical ingredient





 Company News
MC10 & UCB, Inc. (UCBJF.PK) Partner For Innovative Solutions For Patients With Neurological Disorders 7/28/2014 8:59:03 AM
Wilex AG (WL6.DE) Sends Back Some Promising Drugs To UCB, Inc. (UCBJF.PK) In Effort To Stay Alive 5/22/2014 7:36:33 AM
UCB, Inc. (UCBJF.PK) Announces Data From First Seven Year Evaluation Of Cimzia® (Certolizumab Pegol) In Moderate To Severe Crohn's Disease Patients 5/5/2014 8:54:03 AM
Sanofi (France) (SAN.PA), UCB, Inc. (UCBJF.PK) Strikes $138 Million Pact To Seek Anti-Inflammatory Small Molecules 3/11/2014 7:39:07 AM
UCB, Inc. (UCBJF.PK) CEO Out, Biopharma Chief Appointed To Top Post 2/20/2014 7:25:06 AM
UCB, Inc. (UCBJF.PK) And UK's MRC Technology Sign Exclusive License Agreement For A Fibrosis Program 2/13/2014 9:48:29 AM
Biogen, Inc. And UCB, Inc. (UCBJF.PK) Enter Agreements To Commercialize Multiple Sclerosis And Hemophilia Therapies In Asia 1/30/2014 11:56:57 AM
InteRNA Technologies, UCB, Inc. (UCBJF.PK) And University of Bonn To Collaborate On The Role Of MicroRNAs In Neurodegenerative Disease 1/10/2014 9:04:55 AM
Amgen (AMGN), UCB, Inc. (UCBJF.PK): Osteoporosis Phase 2 Drug Trial A Success 1/2/2014 6:35:53 AM
Oncodesign SA And UCB, Inc. (UCBJF.PK) Enter Into A Research Collaboration For The Early Development Of New Therapeutic Agents In Neurodegenerative Diseases 11/13/2013 9:06:53 AM
12345678910...